Hadasit Bio (HDST) — Financial Flexibility Index

Latest as of June 2022: -0.33x

Hadasit Bio (HDST) has a Financial Flexibility Index of -0.33x as of June 2022. Free cash flow of ILA-360.50K (operating CF ILA-360.50K minus capex ILA0.00) represents 0% of total liabilities (ILA1.10 Million). Check HDST strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

-0.33x
Free Cash Flow / Total Liabilities

Free Cash Flow

ILA-360.50K
Operating CF − Capex

Total Liabilities

ILA1.10 Million
ILA

Capital Expenditures

ILA0.00
ILA

Hadasit Bio Financial Flexibility Index (2013–2022)

Historical Financial Flexibility Index trend for Hadasit Bio across 10 annual periods. See how liquid is Hadasit Bio's working capital to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Hadasit Bio (2013–2022)

Year-by-year free cash flow to debt coverage for Hadasit Bio. For the full company profile including market capitalisation, see Hadasit Bio (HDST) total market value.

Year Flexibility Index Free Cash Flow (ILA) Operating CF Total Liabilities YoY Change
2022 -0.55x ILA-2.12 Million ILA-2.12 Million ILA3.88 Million ▲ +81.2%
2021 -2.90x ILA-2.10 Million ILA-2.10 Million ILA722.00K ▼ -213.3%
2020 -0.93x ILA-3.96 Million ILA-3.96 Million ILA4.27 Million ▼ -14.2%
2019 -0.81x ILA-3.17 Million ILA-3.18 Million ILA3.91 Million ▲ +94.8%
2018 -15.48x ILA-15.99 Million ILA-16.46 Million ILA1.03 Million ▼ -599.5%
2017 -2.21x ILA-17.29 Million ILA-17.57 Million ILA7.81 Million ▼ -20.9%
2016 -1.83x ILA-14.34 Million ILA-14.68 Million ILA7.84 Million ▼ -14.8%
2015 -1.59x ILA-13.24 Million ILA-13.26 Million ILA8.31 Million ▼ -35.2%
2014 -1.18x ILA-12.15 Million ILA-12.24 Million ILA10.31 Million ▼ -3.5%
2013 -1.14x ILA-11.24 Million ILA-11.61 Million ILA9.87 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities